Assignee
Chemapotheca LLC
US·7 granted patents·1 pending application·34 citations·filing 2014–2020
Top patents by PatentIndex Score
8 records- 0194US9657041B2Chiral aryl or aryl-alkyl phosphoramidate dexamphetamine precursors having a regioisomeric purity >99%Chemapotheca LLC·Filed 2016·Granted May 23, 2017·9 cites·11 claims
- 0293US10087202B2Chiral aziridine phosphoramidate compoundsChemapotheca LLC·Filed 2017·Granted Oct 2, 2018·6 cites·6 claims
- 0391US9278904B2Synthesis of chiral amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compoundsChemapotheca LLC·Filed 2014·Granted Mar 8, 2016·7 cites·20 claims
- 0490US11123310B2Amphetamine controlled release, prodrug, and abuse-deterrent dosage formsChemapotheca LLC·Filed 2017·Granted Sep 21, 2021·4 cites·43 claims
- 0589US9321794B2Synthesis of racemic amphetamine derivatives by cuprate addition reaction with aziridine phosphoramidate compoundsChemapotheca LLC·Filed 2014·Granted Apr 26, 2016·7 cites·29 claims
- 0675US12006275B2Process for making levoamphetamineChemapotheca LLC·Filed 2020·Granted Jun 11, 2024·1 cites·20 claims
- 0766US11717498B2Methods of treatment using amphetamine controlled release, prodrug, and abuse deterrent dosage formsChemapotheca LLC·Filed 2020·Granted Aug 8, 2023·0 cites·32 claims
- 0863US2020352883A1Methods of treatment using amphetamine controlled release, prodrug, and abuse-deterrent dosage formsChemapotheca LLC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →